Login to Your Account



Stem cell-derived EPO-producing cells can ameliorate renal anemia

By John Fox
Staff Writer

Tuesday, October 3, 2017

Erythropoietin (EPO)-producing cells derived from human induced pluripotent stem (iPS) cells have been shown for the first time to be capable of successfully treating renal anemia in mice, Japanese researchers reported in the Sept. 27, 2017, edition of Science Translational Medicine.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription